• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

袖状胃切除术后 BMI≤30kg/m2 的患者短期糖尿病缓解的结果。

Short-Term Diabetes Remission Outcomes in Patients with BMI ≤ 30 kg/m Following Sleeve Gastrectomy.

机构信息

Department of General Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221002, Jiangsu, People's Republic of China.

出版信息

Obes Surg. 2020 Jan;30(1):18-22. doi: 10.1007/s11695-019-04139-1.

DOI:10.1007/s11695-019-04139-1
PMID:31428971
Abstract

BACKGROUND

Sleeve gastrectomy (SG) has become the most popular bariatric procedure. Although bariatric surgery is recommended for type 2 diabetes mellitus (T2DM) in Asian patients with BMI 27.5-32.4 kg/m, reported evidences, especially following SG, are still lacking.

METHODS

Patients' data from June 2016 to June 2018 that underwent SG as primary surgery at our setting were analyzed. Patients with T2DM, without insulin use and BMI 27.5-30 kg/m, were our main criteria. Preoperative and postoperative parameters were as such: age, BMI, T2DM duration, anti-diabetic medications, fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c), insulin, C-peptide, and homeostatic model assessment-insulin resistance (HOMA-IR). Follow-up duration was at 1, 3, 6, and 12 months.

RESULTS

Eighteen patients (7 male and 11 female) were presented for this study. The mean age and diabetes duration were 46.3 ± 11.9 years and 31.8 ± 26.5 months, respectively. The mean preoperative vs postoperative 12-month assessment was as such: BMI 29.3 ± 0.9 vs 23.9 ± 0.9 kg/m, FPG 8.4 ± 3.1 vs 5.6 ± 0.7 mmol/L, HbA1c 8.3 ± 1.8 vs 5.9 ± 0.7%, insulin 103.9 ± 47.4 vs 53.9 ± 13.1 pmol/L, C-peptide 1.90 ± 1.22 vs 1.08 ± 0.44 ng/ml, and HOMA-IR 5.5 ± 4.0 vs 1.9 ± 0.6, all reached statistical significance (p value < 0.05).

CONCLUSIONS

In short-term, and also under strict selection criteria, SG can result in both improvement and remission of T2DM in patients with BMI 27.5-30 kg/m. Larger sample size and longer follow-up duration will be needed in the future.

摘要

背景

袖状胃切除术(SG)已成为最受欢迎的减肥手术。尽管亚洲患者 BMI 为 27.5-32.4kg/m 时,推荐进行减重手术以治疗 2 型糖尿病(T2DM),但仍缺乏相关报告证据,尤其是在 SG 之后。

方法

分析了 2016 年 6 月至 2018 年 6 月期间在我院行 SG 作为初次手术的患者数据。我们的主要标准是 T2DM 患者、未使用胰岛素且 BMI 为 27.5-30kg/m。分析术前和术后的以下参数:年龄、BMI、T2DM 持续时间、降糖药物、空腹血糖(FPG)、糖化血红蛋白(HbA1c)、胰岛素、C 肽和稳态模型评估-胰岛素抵抗(HOMA-IR)。随访时间为 1、3、6 和 12 个月。

结果

本研究共纳入 18 例患者(7 例男性和 11 例女性)。平均年龄和糖尿病病程分别为 46.3±11.9 岁和 31.8±26.5 个月。与术后 12 个月的平均评估相比:BMI 从 29.3±0.9kg/m 降至 23.9±0.9kg/m、FPG 从 8.4±3.1mmol/L 降至 5.6±0.7mmol/L、HbA1c 从 8.3±1.8%降至 5.9±0.7%、胰岛素从 103.9±47.4pmol/L 降至 53.9±13.1pmol/L、C 肽从 1.90±1.22ng/ml 降至 1.08±0.44ng/ml、HOMA-IR 从 5.5±4.0 降至 1.9±0.6,均具有统计学意义(p 值均<0.05)。

结论

在短期内,并且在严格的选择标准下,SG 可以使 BMI 为 27.5-30kg/m 的 T2DM 患者的 T2DM 得到改善和缓解。未来需要更大的样本量和更长的随访时间。

相似文献

1
Short-Term Diabetes Remission Outcomes in Patients with BMI ≤ 30 kg/m Following Sleeve Gastrectomy.袖状胃切除术后 BMI≤30kg/m2 的患者短期糖尿病缓解的结果。
Obes Surg. 2020 Jan;30(1):18-22. doi: 10.1007/s11695-019-04139-1.
2
[Mid-term efficacy of single anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of obesity and type 2 diabetes mellitus].单吻合十二指肠-回肠旁路术联合袖状胃切除术治疗肥胖症和2型糖尿病的中期疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2024 Oct 25;27(10):1056-1062. doi: 10.3760/cma.j.cn441530-20231007-00117.
3
Five-Year-Results of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass for Weight Loss and Type 2 Diabetes Mellitus.腹腔镜袖状胃切除术联合十二指肠空肠旁路术治疗肥胖症和2型糖尿病的五年随访结果
Obes Surg. 2017 Mar;27(3):795-801. doi: 10.1007/s11695-016-2372-0.
4
Laparoscopic Ileal Interposition with Diverted Sleeve Gastrectomy Versus Laparoscopic Transit Bipartition with Sleeve Gastrectomy for Better Glycemic Outcomes in T2DM Patients.腹腔镜回肠插入术联合袖状胃切除术转流与腹腔镜袖状胃切除术转流二分法对2型糖尿病患者改善血糖结局的比较
Obes Surg. 2018 Jan;28(1):77-86. doi: 10.1007/s11695-017-2803-6.
5
[Effect of laparoscopic sleeve gatrectomy on type 2 diabetes mellitus in obese patients with body mass index less than 40 kg/m].[腹腔镜袖状胃切除术对体重指数小于40kg/m²的肥胖患者2型糖尿病的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Apr 25;20(4):400-404.
6
Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.腹腔镜袖状胃切除术治疗非病态肥胖糖尿病患者的疗效及胰岛素分泌变化。
Surgery. 2010 May;147(5):664-9. doi: 10.1016/j.surg.2009.10.059. Epub 2009 Dec 11.
7
Obese Patients with Type 2 Diabetes: Outcomes After Laparoscopic Sleeve Gastrectomy.肥胖的2型糖尿病患者:腹腔镜袖状胃切除术后的结果
J Laparoendosc Adv Surg Tech A. 2019 May;29(5):655-662. doi: 10.1089/lap.2018.0652. Epub 2018 Nov 16.
8
The Effects of Laparoscopic Sleeve Gastrectomy with Duodenojejunal Bypass on Japanese Patients with BMI < 35 kg/m on Type 2 Diabetes Mellitus and the Prediction of Successful Glycemic Control.腹腔镜袖状胃切除术联合十二指肠空肠旁路术对日本体重指数(BMI)<35kg/m²的2型糖尿病患者的影响及血糖控制成功的预测
Obes Surg. 2018 Aug;28(8):2429-2438. doi: 10.1007/s11695-018-3179-y.
9
Mid-Term Diabetes Remission Outcome in Patients with BMI ≤ 30 kg/m Following Sleeve Gastrectomy.BMI≤30kg/m2 的患者行袖状胃切除术的中期糖尿病缓解结局。
Obes Surg. 2024 May;34(5):1491-1495. doi: 10.1007/s11695-024-07112-9. Epub 2024 Feb 26.
10
Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect.腹腔镜袖状胃切除术与单吻合口(迷你)胃旁路术治疗2型糖尿病:一项随机试验的5年结果及肠促胰岛素效应研究
Obes Surg. 2014 Sep;24(9):1552-62. doi: 10.1007/s11695-014-1344-5.

引用本文的文献

1
Clarifying the 2022 IFSO/ASMBS Metabolic and Bariatric Surgery Guidelines for Asians: Safeguarding Against Misapplication.解读2022年国际肥胖与代谢病外科学会(IFSO)/美国代谢与减重外科学会(ASMBS)亚洲人代谢与减重手术指南:谨防误用
Obes Surg. 2025 Sep 1. doi: 10.1007/s11695-025-08237-1.
2
Robotic vs Laparoscopic Sleeve Gastrectomy in Patients with BMI > 40 kg/m (Class ≥ III Obesity): A Systematic Review and Meta-Analysis.体重指数>40kg/m²(≥Ⅲ级肥胖)患者的机器人与腹腔镜袖状胃切除术:一项系统评价和荟萃分析
Obes Surg. 2025 Apr 17. doi: 10.1007/s11695-025-07881-x.
3
"Metabolic surgery in Asian patients with type 2 diabetes mellitus and body mass index less than 30kg/m2: A systematic review".

本文引用的文献

1
Predicting remission of diabetes post metabolic surgery: a comparison of ABCD, diarem, and DRS scores.预测代谢手术后糖尿病缓解:ABCD、diarem 和 DRS 评分的比较。
Obes Surg. 2018 Jul;28(7):2025-2031. doi: 10.1007/s11695-018-3136-9.
2
The Predictive Factors for Diabetic Remission in Chinese Patients with BMI > 30 kg/m and BMI < 30 kg/m Are Different.中国 BMI>30kg/m² 和 BMI<30kg/m² 的糖尿病患者缓解的预测因素不同。
Obes Surg. 2018 Jul;28(7):1943-1949. doi: 10.1007/s11695-017-3106-7.
3
7. Obesity Management for the Treatment of Type 2 Diabetes: .
亚洲2型糖尿病且体重指数低于30kg/m²患者的代谢手术:一项系统评价
Obes Pillars. 2024 Oct 21;12:100145. doi: 10.1016/j.obpill.2024.100145. eCollection 2024 Dec.
4
Scientific Evidence for the Updated Guidelines on Indications for Metabolic and Bariatric Surgery (IFSO/ASMBS).代谢和减重手术适应证更新指南的科学证据(IFSO/ASMBS)。
Obes Surg. 2024 Nov;34(11):3963-4096. doi: 10.1007/s11695-024-07370-7. Epub 2024 Sep 25.
5
Incidence rate and implications of splenic ischemia during sleeve gastrectomy and its related procedure.袖状胃切除术及其相关手术中脾缺血的发生率及意义。
Medicine (Baltimore). 2024 Mar 1;103(9):e37276. doi: 10.1097/MD.0000000000037276.
6
Weight Loss, Type 2 Diabetes, and Nutrition in 355 Patients with Obesity Undergoing Sleeve Gastrectomy with Transit Bipartition: Two-Year Outcomes.355 例接受转流分块袖状胃切除术肥胖患者的减重、2 型糖尿病和营养:两年结果。
Obes Facts. 2022;15(5):717-729. doi: 10.1159/000526718. Epub 2022 Sep 7.
7
Safety of peripheral gastric vessel coagulation during laparoscopic sleeve gastrectomy.腹腔镜袖状胃切除术期间胃周血管凝血的安全性
J Minim Access Surg. 2022 Apr-Jun;18(2):197-200. doi: 10.4103/jmas.JMAS_1_21.
8
Comparing the Anti-diabetic Effect of Sleeve Gastrectomy with Transit Bipartition Against Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Using a Diabetic Rodent Model.比较袖状胃切除术与转流式双通道吻合术对比袖状胃切除术和 Roux-en-Y 胃旁路术对糖尿病大鼠模型的降糖效果。
Obes Surg. 2021 May;31(5):2203-2210. doi: 10.1007/s11695-021-05256-6. Epub 2021 Jan 28.
9
Short-Term Results Suggest That Sleeved Stomach without Resection Is as Effective as Sleeve Gastrectomy in Improving Glucose Control in Type 2 Diabetes Mellitus Sprague-Dawley Rat Model.短期结果表明,在改善 2 型糖尿病斯普拉格-道利大鼠模型的血糖控制方面,套管胃而不切除与袖状胃切除术同样有效。
Biomed Res Int. 2020 May 1;2020:9024923. doi: 10.1155/2020/9024923. eCollection 2020.
7. 肥胖症管理用于 2 型糖尿病的治疗: 。
Diabetes Care. 2018 Jan;41(Suppl 1):S65-S72. doi: 10.2337/dc18-S007.
4
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27. doi: 10.2337/dc18-S002.
5
Three-year result of efficacy for type 2 diabetes mellitus control between laparoscopic duodenojejunal bypass compared with laparoscopic Roux-en-Y gastric bypass.腹腔镜十二指肠空肠旁路术与腹腔镜Roux-en-Y胃旁路术治疗2型糖尿病疗效的三年结果对比
Ann Surg Treat Res. 2017 Nov;93(5):260-265. doi: 10.4174/astr.2017.93.5.260. Epub 2017 Oct 27.
6
Laparoscopic Sleeve Gastrectomy Versus Banded Roux-en-Y Gastric Bypass for Diabetes and Obesity: a Prospective Randomised Double-Blind Trial.腹腔镜袖状胃切除术与带环 Roux-en-Y 胃旁路术治疗糖尿病和肥胖症:一项前瞻性随机双盲试验
Obes Surg. 2018 Feb;28(2):293-302. doi: 10.1007/s11695-017-2872-6.
7
Gastric mucosal devitalization reduces adiposity and improves lipid and glucose metabolism in obese rats.胃黏膜去活术可减少肥胖大鼠的肥胖程度,改善其脂代谢和糖代谢。
Gastrointest Endosc. 2018 Jan;87(1):288-299.e6. doi: 10.1016/j.gie.2017.04.038. Epub 2017 May 4.
8
Metabolic Flexibility in Health and Disease.健康与疾病中的代谢灵活性
Cell Metab. 2017 May 2;25(5):1027-1036. doi: 10.1016/j.cmet.2017.04.015.
9
Predictive Value of Gut Peptides in T2D Remission: Randomized Controlled Trial Comparing Metabolic Gastric Bypass, Sleeve Gastrectomy and Greater Curvature Plication.肠道肽在2型糖尿病缓解中的预测价值:比较代谢性胃旁路术、袖状胃切除术和大弯折叠术的随机对照试验
Obes Surg. 2017 Sep;27(9):2235-2245. doi: 10.1007/s11695-017-2669-7.
10
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.减肥手术与强化药物治疗糖尿病——5年结果
N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869.